GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances
Novo, the maker of GLP-1s Ozempic and Wegovy, claims that Eli Lillys ads for its competing GLP-1 brands, Mounjaro and Zepbound, rely on deceptive advertising that has caused widespread confusion in the marketplace
Krishnan PA et al
Both are widely known for their skin-brightening benefits, but they work in different ways
At Pure Medical Spa , GLP-1 therapy is offered as part of a personalized medical weight loss Chicago program tailored to each patients health profile and weight loss goals
10.3389/fneur.2019.00218 Front